With 56% institutional ownership, Altimmune, Inc. (NASDAQ:ALT) is a favorite amongst the big guns [Yahoo! Finance]
Altimmune to Host Virtual R&D Day on March 13, 2025 [Yahoo! Finance]
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Altimmune, Inc. (NASDAQ: ALT) had its "market perform" rating re-affirmed by analysts at William Blair.